Home » Merck Restarts Cholesterol Race Four Years After Pfizer Failure
Merck Restarts Cholesterol Race Four Years After Pfizer Failure
Merck & Co. is betting it can succeed where Pfizer Inc. failed, with a new type of drug to combat heart disease by raising good cholesterol levels.
Bloomberg
Bloomberg
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May